GenMark Seeks FDA OK for Respiratory Viral Panel | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics today said that it has filed with the US Food and Drug Administration for 510(k) clearance of its Respiratory Viral Panel.

The test would run on the firm's eSensor XT-8 and is designed to identify multiple viruses from patients exhibiting symptoms of respiratory infection. The Carlsbad, Calif.-based firm previously stated that the test would detect 21 upper respiratory viruses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.